These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1293 related articles for article (PubMed ID: 9107426)

  • 21. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer.
    Bell DA; Stephens EA; Castranio T; Umbach DM; Watson M; Deakin M; Elder J; Hendrickse C; Duncan H; Strange RC
    Cancer Res; 1995 Aug; 55(16):3537-42. PubMed ID: 7627961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Relationship between genetic polymorphism of NAT2 and susceptibility to urinary bladder cancer].
    Hao GY; Zhang WD; Chen YH; Zhang DX; Zhang YH
    Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):283-6. PubMed ID: 15312364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.
    Probst-Hensch NM; Bell DA; Watson MA; Skipper PL; Tannenbaum SR; Chan KK; Ross RK; Yu MC
    Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):619-23. PubMed ID: 10868698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer.
    Chen J; Stampfer MJ; Hough HL; Garcia-Closas M; Willett WC; Hennekens CH; Kelsey KT; Hunter DJ
    Cancer Res; 1998 Aug; 58(15):3307-11. PubMed ID: 9699660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.
    Song DK; Xing DL; Zhang LR; Li ZX; Liu J; Qiao BP
    Cancer Detect Prev; 2009; 32(5-6):416-23. PubMed ID: 19303722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of arylamine N-acetyltransferases NAT1 and NAT2 genotypes to laryngeal cancer risk.
    Henning S; Cascorbi I; Münchow B; Jahnke V; Roots I
    Pharmacogenetics; 1999 Feb; 9(1):103-11. PubMed ID: 10208649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer.
    Alberg AJ; Daudt A; Huang HY; Hoffman SC; Comstock GW; Helzlsouer KJ; Strickland PT; Bell DA
    Cancer Detect Prev; 2004; 28(3):187-93. PubMed ID: 15225898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Para-phenylenediamine and allergic sensitization: risk modification by N-acetyltransferase 1 and 2 genotypes.
    Blömeke B; Brans R; Coenraads PJ; Dickel H; Bruckner T; Hein DW; Heesen M; Merk HF; Kawakubo Y
    Br J Dermatol; 2009 Nov; 161(5):1130-5. PubMed ID: 19663877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer.
    Broberg K; Björk J; Paulsson K; Höglund M; Albin M
    Carcinogenesis; 2005 Jul; 26(7):1263-71. PubMed ID: 15746160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NAT2 fast acetylator genotype is associated with an increased risk of colorectal cancer in Taiwan.
    Huang CC; Chien WP; Wong RH; Cheng YW; Chen MC; Chou MC; Lee H
    Dis Colon Rectum; 2007 Jul; 50(7):981-9. PubMed ID: 17525862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
    Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
    Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inherited GSTM1 and NAT2 defects as concurrent risk modifiers in asbestos-related human malignant mesothelioma.
    Hirvonen A; Pelin K; Tammilehto L; Karjalainen A; Mattson K; Linnainmaa K
    Cancer Res; 1995 Jul; 55(14):2981-3. PubMed ID: 7606714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
    Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
    Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of the genotypes for N-acetyltransferases 1 and 2 with double bladder and prostate cancers in a case-comparison study.
    Wang CY; Jones RF; Debiec-Rychter M; Soos G; Haas GP
    Anticancer Res; 2002; 22(6B):3529-35. PubMed ID: 12552951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glutathione S-transferase M1 and its variants A and B as host factors of bladder cancer susceptibility: a case-control study.
    Brockmöller J; Kerb R; Drakoulis N; Staffeldt B; Roots I
    Cancer Res; 1994 Aug; 54(15):4103-11. PubMed ID: 8033143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women.
    McGrath M; Michaud D; De Vivo I
    BMC Cancer; 2006 Oct; 6():239. PubMed ID: 17026750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cumulative genetic defects in carcinogen metabolism may increase breast cancer risk (The Netherlands).
    van der Hel OL; Bueno-de-Mesquita HB; van Gils CH; Roest M; Slothouber B; Grobbee DE; Peeters PH
    Cancer Causes Control; 2005 Aug; 16(6):675-81. PubMed ID: 16049806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-acetyltransferase 2 and bladder cancer: an overview and consideration of the evidence for gene-environment interaction.
    Green J; Banks E; Berrington A; Darby S; Deo H; Newton R
    Br J Cancer; 2000 Aug; 83(3):412-7. PubMed ID: 10917561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NAT2*7 allele is a potential risk factor for adult brain tumors in Taiwanese population.
    Liu HE; Hsiao PY; Lee CC; Lee JA; Chen HY
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):661-5. PubMed ID: 18349284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequence variants of NAT1 and NAT2 and other xenometabolic genes and risk of lung and aerodigestive tract cancers in Central Europe.
    McKay JD; Hashibe M; Hung RJ; Wakefield J; Gaborieau V; Szeszenia-Dabrowska N; Zaridze D; Lissowska J; Rudnai P; Fabianova E; Mates D; Foretova L; Janout V; Bencko V; Chabrier A; Hall J; Boffetta P; Canzian F; Brennan P
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):141-7. PubMed ID: 18199719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 65.